Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
DermaSilk mini shorts extra large-XX large adult female
20200000326
|
DermaSilk mini shorts extra large-XX large adult female | Silk Garments | Dressings | No data available |
|
DermaSilk soft cup bra extra large-XX large
20200000323
|
DermaSilk soft cup bra extra large-XX large | Silk Garments | Dressings | No data available |
|
DermaSilk soft cup bra extra small-small
20200000321
|
DermaSilk soft cup bra extra small-small | Silk Garments | Dressings | No data available |
|
DermaSilk soft cup bra medium-large
20200000322
|
DermaSilk soft cup bra medium-large | Silk Garments | Dressings | No data available |
|
Dermasure wound drainage bag medium
20031500031
|
Dermasure wound drainage bag medium | Wound Management & Other Dressings | Dressings | No data available |
|
Dermasure wound drainage bag small
20031500030
|
Dermasure wound drainage bag small | Wound Management & Other Dressings | Dressings | No data available |
|
Dermatix spray
20031400017
|
Dermatix spray | Wound Management & Other Dressings | Dressings | No data available |
|
Dermestril - Septem 50 patches
0604011G0BNAEBL
|
Dermestril | Estradiol | Endocrine System | No data available |
|
Dermestril - Septem 75 patches
0604011G0BNAFBR
|
Dermestril | Estradiol | Endocrine System | No data available |
|
Dermestril 100 patches
0604011G0BNACBN
|
Dermestril | Estradiol | Endocrine System | No data available |
|
Dermestril 25 patches
0604011G0BNAABA
|
Dermestril | Estradiol | Endocrine System | No data available |
|
Dermestril 50 patches
0604011G0BNABBL
|
Dermestril | Estradiol | Endocrine System | No data available |
|
Dermidex Dermatological cream
130300000BPASA0
|
Proprietary compound preparation BNF 1303000 | Other topical anaesthetic and antipruritic preparations | Skin | No data available |
|
Dermisplus Contact dressing 5cm x 5cm
20033000042
|
Dermisplus Contact dressing 5cm x 5cm | Wound Management & Other Dressings | Dressings | No data available |
|
Deseril 1mg tablets
0407042L0BBAAAA
|
Deseril | Methysergide | Central Nervous System | No data available |
|
Desferal 2g powder for solution for injection vials
0901030P0BBACAH
|
Desferal | Desferrioxamine mesilate | Nutrition and Blood | No data available |
|
Desferal 500mg powder for solution for injection vials
0901030P0BBAAAA
|
Desferal | Desferrioxamine mesilate | Nutrition and Blood | No data available |
|
Desferrioxamine 2g powder for solution for injection vials
0901030P0AAAHAH
|
Desferriox mesilate | Desferrioxamine mesilate | Nutrition and Blood | No data available |
|
Desferrioxamine 500mg inj vials
0901030P0AAAAAA
|
Desferriox mesilate | Desferrioxamine mesilate | Nutrition and Blood | No data available |
|
Desloratadine 2.5mg/5ml oral solution
0304010ABAAABAB
|
Desloratadine | Desloratadine | Respiratory System | No data available |
|
Desmopressin 100micrograms/5ml oral liquid
0605020E0AAAYAY
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | No data available |
|
Desmopressin 12.5microgram capsules
0605020E0AAALAL
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | No data available |
|
Desmopressin 150micrograms/dose nasal spray
0605020E0AAASAS
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | No data available |
|
Desmopressin 15micrograms/1ml inj ampoules
0605020E0AABKBK
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | No data available |
|
Desmopressin 250micrograms/5ml oral liquid
0605020E0AABJBJ
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.